Follow
Francesca Colavita
Francesca Colavita
National Institute for Infectious Diseases "Lazzaro Spallanzani"
Verified email at inmi.it
Title
Cited by
Cited by
Year
SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection
F Colavita, D Lapa, F Carletti, E Lalle, L Bordi, P Marsella, E Nicastri, ...
Annals of internal medicine 173 (3), 242-243, 2020
4692020
Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa
MW Carroll, DA Matthews, JA Hiscox, MJ Elmore, G Pollakis, A Rambaut, ...
Nature 524 (7563), 97-101, 2015
3722015
Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding
D Lapa, F Carletti, V Mazzotta, G Matusali, C Pinnetti, S Meschi, ...
The Lancet Infectious Diseases 22 (9), 1267-1269, 2022
2132022
2019-novel coronavirus severe adult respiratory distress syndrome in two cases in Italy: an uncommon radiological presentation
F Albarello, E Pianura, F Di Stefano, M Cristofaro, A Petrone, L Marchioni, ...
International Journal of Infectious Diseases 93, 192-197, 2020
2092020
Humoral-and T-cell–specific immune responses to SARS-CoV-2 mRNA vaccination in patients with MS using different disease-modifying therapies
C Tortorella, A Aiello, C Gasperini, C Agrati, C Castilletti, S Ruggieri, ...
Neurology 98 (5), e541-e554, 2022
1552022
Tropism of the chikungunya virus
G Matusali, F Colavita, L Bordi, E Lalle, G Ippolito, MR Capobianchi, ...
Viruses 11 (2), 175, 2019
1212019
Blood kinetics of Ebola virus in survivors and nonsurvivors.
IG Lanini S, Portella G, Vairo F, Kobinger GP, Pesenti A, Langer M, Kabia S ...
J Clin Invest. 125 (12), 4692-8, 2015
1142015
Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis
R Nardacci, F Colavita, C Castilletti, D Lapa, G Matusali, S Meschi, ...
Cell death & disease 12 (3), 263, 2021
1122021
Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy
MR Capobianchi, M Rueca, F Messina, E Giombini, F Carletti, F Colavita, ...
Clinical Microbiology and Infection 26 (7), 954-956, 2020
1102020
Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples
FM Liotti, G Menchinelli, E Lalle, I Palucci, S Marchetti, F Colavita, ...
Clinical Microbiology and Infection 27 (3), 487-488, 2021
992021
Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections
S Terreri, EP Mortari, MR Vinci, C Russo, C Alteri, C Albano, F Colavita, ...
Cell host & microbe 30 (3), 400-408. e4, 2022
972022
Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test
S Meschi, F Colavita, L Bordi, G Matusali, D Lapa, A Amendola, F Vairo, ...
Journal of Clinical Virology 129, 104539, 2020
902020
Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa™ COVID-19 direct assay
L Bordi, A Piralla, E Lalle, F Giardina, F Colavita, M Tallarita, G Sberna, ...
Journal of Clinical Virology 128, 104416, 2020
852020
Humoral and cellular immune response elicited by mRNA vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in people living with human …
A Antinori, S Cicalini, S Meschi, V Bordoni, P Lorenzini, A Vergori, ...
Clinical Infectious Diseases 75 (1), e552-e563, 2022
832022
Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt’s lymphoma cells by affecting multiple molecular targets
A De Leo, G Arena, E Lacanna, G Oliviero, F Colavita, E Mattia
Antiviral research 96 (2), 196-202, 2012
832012
Coronavirus disease (COVID-19) in a paucisymptomatic patient: epidemiological and clinical challenge in settings with limited community transmission, Italy, February 2020
E Nicastri, A D’Abramo, G Faggioni, R De Santis, A Mariano, L Lepore, ...
Eurosurveillance 25 (11), 2000230, 2020
792020
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
A Vergori, A Cozzi Lepri, S Cicalini, G Matusali, V Bordoni, S Lanini, ...
Nature Communications 13 (1), 4922, 2022
782022
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models
A Conforti, E Marra, F Palombo, G Roscilli, M Ravą, V Fumagalli, A Muzi, ...
Molecular Therapy 30 (1), 311-326, 2022
662022
SARS-CoV-2 serum neutralization assay: a traditional tool for a brand-new virus
G Matusali, F Colavita, D Lapa, S Meschi, L Bordi, P Piselli, R Gagliardini, ...
Viruses 13 (4), 655, 2021
652021
Coordinate induction of humoral and spike specific T-cell response in a cohort of Italian health care workers receiving BNT162b2 mRNA vaccine
C Agrati, C Castilletti, D Goletti, S Meschi, A Sacchi, G Matusali, V Bordoni, ...
Microorganisms 9 (6), 1315, 2021
632021
The system can't perform the operation now. Try again later.
Articles 1–20